Spatial profiling of longitudinal glioblastoma reveals consistent changes in cellular architecture, post-treatment
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Glioblastoma (GBM), the most aggressive adult brain cancer, comprises a complex tumour microenvironment (TME) with diverse cellular interactions driving progression and pathobiology. How these spatial patterns and interactions evolve with treatment remains unclear. Here, we apply imaging mass cytometry to analyse protein-level changes in paired pre- and post-treatment GBM samples from five patients. We find a significant post-treatment increase in normal brain cells alongside a reduction in vascular cells. Moreover, despite minimal overall change in cellular diversity, interactions among astrocytes, oligodendrocytes, and vascular cells increase post-treatment, suggesting reorganisation of the TME. The GBM TME cells form spatially organized layers driven by hypoxia pre-treatment, but this influence diminishes post-treatment, giving way to less organised layers with organisation driven by reactive astrocytes and lymphocytes. These findings provide insight into treatment-induced shifts in GBM’s cellular landscape, highlighting aspects of the evolving TME that appear to facilitate recurrence and are, therefore, potential therapeutic targets.
Key points
-
Spatial organisation in primary GBM consist of layers driven by the presence of hypoxia
-
The layers in recurrent GBM appear are driven more by the presence of reactive astrocytes
-
Increased cellular cross-talk in recurrent GBM presents novel therapeutic targets
